Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
Newly Identified Gait Patterns in Patient With Multiple Sclerosis May Be Related to Push-Off Quality.
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
Olfactory dysfunction in patients with multiple sclerosis.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
Papers: 31 Jul 2014 - 7 Aug 2014
Level of education and multiple sclerosis risk over a 50-year period: Registry-based sibling study.
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
Papers: 5 Feb 2016 - 12 Feb 2016
Improving Clinical Outcomes and Health Care Resources Utilization in Multiple Sclerosis: A Portuguese Hospital Perspective.
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis.
MS Research Roundup: May 27, 2014
Difficulties in adjustment to multiple sclerosis: vulnerability and unpredictability of illness in the foreground.
Pediatric Optic Neuritis Prospective Outcomes Study.
Mucocele After Orbital Fracture Repair Masquerading as Optic Neuritis.
Information processing speed in multiple sclerosis: Past, present, and future.
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Papers: 21 Aug 2015 - 28 Aug 2015
Accurate MS Information for Your Patients
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »